Bei Xu

657 total citations
11 papers, 543 citations indexed

About

Bei Xu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Bei Xu has authored 11 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Bei Xu's work include Neurological Disease Mechanisms and Treatments (3 papers), Flavonoids in Medical Research (3 papers) and Phytochemistry and Biological Activities (2 papers). Bei Xu is often cited by papers focused on Neurological Disease Mechanisms and Treatments (3 papers), Flavonoids in Medical Research (3 papers) and Phytochemistry and Biological Activities (2 papers). Bei Xu collaborates with scholars based in China. Bei Xu's co-authors include Guanhua Du, Xin Mu, Guorong He, Xiaoxiu Li, Juanjuan Hu, Shuo Tian, Tiantai Zhang, Mei Gao, Jia Chen and Robert Chunhua Zhao and has published in prestigious journals such as Scientific Reports, European Journal of Pharmacology and Pharmacology Biochemistry and Behavior.

In The Last Decade

Bei Xu

11 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bei Xu China 8 180 163 126 109 93 11 543
Jeong Seon Yoon South Korea 18 117 0.7× 547 3.4× 98 0.8× 69 0.6× 115 1.2× 28 997
Nemat Khan Australia 17 92 0.5× 238 1.5× 104 0.8× 35 0.3× 60 0.6× 30 765
Caixia Zang China 16 101 0.6× 318 2.0× 81 0.6× 71 0.7× 184 2.0× 40 733
Jianzong Chen China 16 154 0.9× 516 3.2× 136 1.1× 93 0.9× 105 1.1× 17 830
Jae‐Sun Choi South Korea 14 63 0.3× 272 1.7× 87 0.7× 47 0.4× 42 0.5× 24 672
Limor Kalfon Israel 11 60 0.3× 180 1.1× 62 0.5× 86 0.8× 65 0.7× 27 587
Yu Jin Kim South Korea 14 106 0.6× 182 1.1× 19 0.2× 132 1.2× 94 1.0× 51 547
Jong Hee Choi South Korea 15 58 0.3× 333 2.0× 52 0.4× 79 0.7× 84 0.9× 31 584
Mohammad Yasin Zamanian Iran 18 74 0.4× 225 1.4× 47 0.4× 44 0.4× 41 0.4× 49 621

Countries citing papers authored by Bei Xu

Since Specialization
Citations

This map shows the geographic impact of Bei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Xu more than expected).

Fields of papers citing papers by Bei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Xu. The network helps show where Bei Xu may publish in the future.

Co-authorship network of co-authors of Bei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Xu. A scholar is included among the top collaborators of Bei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Xu. Bei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Lu, Sha Wang, Jinwei Wang, et al.. (2025). Machine learning unveils hypoxia-immune gene hub for clinical stratification of thyroid-associated ophthalmopathy. Scientific Reports. 15(1). 22021–22021. 1 indexed citations
2.
Wang, Xiaohong, et al.. (2024). KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer. Scientific Reports. 14(1). 8284–8284. 6 indexed citations
3.
Sun, Xun, Mengling Liu, Bei Xu, et al.. (2023). Negative correlation between acetyl-CoA acyltransferase 2 and cetuximab resistance in colorectal cancer. Acta Biochimica et Biophysica Sinica. 55(9). 1467–1478. 3 indexed citations
4.
Ding, Xi, Yi‐Jun Hua, Xiong Zou, et al.. (2023). Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 study. EClinicalMedicine. 61. 102043–102043. 8 indexed citations
5.
Sun, Xun, Mengling Liu, Jiayu Zhang, et al.. (2023). JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis. Acta Biochimica et Biophysica Sinica. 55(11). 1784–1796. 8 indexed citations
6.
Ma, Xiaoyang, Jia Chen, Bei Xu, et al.. (2015). Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro. International Journal of Molecular Medicine. 35(5). 1246–1256. 54 indexed citations
7.
He, Guorong, Xin Mu, Bei Xu, et al.. (2011). Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria. European Journal of Pharmacology. 674(2-3). 227–233. 65 indexed citations
8.
Gao, Mei, et al.. (2010). Pinocembrin protects the neurovascular unit by reducing inflammation and extracellular proteolysis in MCAO rats. Journal of Asian Natural Products Research. 12(5). 407–418. 52 indexed citations
9.
Mu, Xin, et al.. (2009). Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacology Biochemistry and Behavior. 92(4). 642–648. 160 indexed citations
10.
Xu, Bei, Xiaoxiu Li, Guorong He, et al.. (2009). Luteolin promotes long-term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats. European Journal of Pharmacology. 627(1-3). 99–105. 69 indexed citations
11.
He, Guorong, Xin Mu, Tiantai Zhang, et al.. (2008). Neuroprotective effect of baicalein against MPTP neurotoxicity: Behavioral, biochemical and immunohistochemical profile. Neuroscience Letters. 441(1). 16–20. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026